Browse All

Current Filters

CLEAR FILTER x

TITLE

A Retrospective Claims Study Evaluating Mortality in Patients With Lennox-Gastaut or Dravet Syndromes in the United States

Author:Ameen, Rejena   Wirrell, Elaine   Sullivan, Joseph   Zuroske, Travis   Grochowski, Devon   Gupta, Shalini   Zhang-Roper, Rebecca   Lothe, Amélie   Kerr, Wesley   

Session Name:P8: Neuroepidemiology  

Topic:Global Health and Neuroepidemiology  

Program Number:P8.004  

Author Institution:UCB, Brussels, Belgium  Mayo Clinic/Dept of Child Neurology, Rochester, MN  University of California San Francisco Weill Institute for Neurosciences, San Francisco, CA  Real Chemistry, New York, NY  University of Pittsburgh, Pittsburgh, PA  

A Retrospective Cohort Study Comparing Persistence Between Rimegepant and Oral Triptans for the Acute Treatment of Migraine in the United States

Author:Jenkins, Aaron   Atkinson, Jo   Dai, Feng   Ho, Martin   Lewis, Motomori   Henriksen, Carl   Abraham, Lucy   

Session Name:P10: Headache: Advances in CGRP Inhibitors and Migraine 3  

Topic:Headache  

Program Number:P10.008  

Author Institution:Pfizer Ltd., Tadworth, United Kingdom  Pfizer Inc. (CA), South San Francisco, CA  

Retrospective Cohort Study: Assessing the Relationship Between Socioeconomic Status and Post-Stroke Vascular Dementia

Author:Lam, Mimi   Al-Khoury, Lama   

Session Name:P5: Aging, Dementia, and Behavioral Neurology: Epidemiology of Cognitive Aging and Dementia 1  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P5.020  

Author Institution:University of California, Riverside (UCR) School of Medicine, Riverside, CA  University of Riverside (UCR) School of Medicine, Riverside, CA  

Retrospective Evaluation of Infusion Tolerability: Ublituximab Real-world Observational Survey (ENAMOR)

Author:Fox, Edward   Sportelli, Peter   Miskin, Hari   Garner, Chris   

Session Name:P7: Multiple Sclerosis: Disease-modifying Therapies: Real-world Evidence and Adverse Events 1  

Topic:Multiple Sclerosis  

Program Number:P7.015  

Author Institution:TG Therapeutics, Round Rock, TX  TG Therapeutics, Stuart, FL  TG Therapeutics, New York, NY  TG Therapeutics, Ozark, MO  

A Retrospective Evaluation of Ocrelizumab and Rituximab Discontinuation in a Canadian Relapsing Multiple Sclerosis Cohort

Author:Hunt, David   Chu, Nathan   kuipers, Donna   west, Kyra   Uy, Christopher   Sayao, Ana-Luiza   Devonshire, Virginia   Schabas, Alice   

Session Name:P7: Multiple Sclerosis: Patient Experience and Patient-reported Outcomes in Multiple Sclerosis and Related Diseases  

Topic:Multiple Sclerosis  

Program Number:P7.005  

Author Institution:University of British Columbia , Vancouver, BC, Canada  University of British Columbia , West Vancouver, BC, Canada